🌊 Negócios em Emersão  ·  Vamos Emergir?  ·  Cadastre-se e ganhe 50 REC de bônus
Notícias

Acompanhe as Notícias da Recifes

Fique por dentro das últimas novidades sobre tecnologia, negócios e empreendedorismo.

740 notícias encontradas para "demon"
26-year-old shot and killed by ICE agent in Maine sparks demonstrations
26-year-old shot and killed by ICE agent in Maine sparks demonstrations
US ICE agents shot and killed a 26-year-old Colombian man in Maine early Monday morning. Department of Homeland Security secretary Markwayne Mullin first said that the man was a target of an ICE investigation and that he had attempted to "weaponise" his vehicle. Later the story c
Six-month results confirm feasibility and early success of first in-human combined bladder
The first-in-human fully vascularized bladder graft transplanted with a kidney has reached a promising six-month milestone, according to a new feasibility study published in The Lancet. The procedure, performed in May 2025, demonstrated technical feasibility and early functional
Intravesical CAR T therapy opens door to bladder-sparing cancer treatment
Researchers at Weill Cornell Medicine, Cedars-Sinai Medical Center and Roswell Park Comprehensive Cancer Center have developed genetically engineered CAR T cells that specifically target and kill bladder cancer cells. The study, published in the Journal of Experimental Medicine (
Foto: Towfiqu barbhuiya / Pexels
Diabetes linked to worse long COVID outcomes
People with diabetes who have had COVID-19 tend to recover more slowly, experience more long COVID complications, have a poorer quality of life, and require closer and more prolonged monitoring by medical teams. This was demonstrated in a study by the University of São Paulo, whi
Cancer cell 'degraders' target two proteins at once to defeat treatment resistance
Cancer cell 'degraders' target two proteins at once to defeat treatment resistance
Researchers from two Technion faculties have jointly developed a new compound and demonstrated its effectiveness against aggressive tumor cells.
AI-guided pathology analysis can help predict immunotherapy response in rare cancers
Researchers from The University of Texas MD Anderson Cancer Center demonstrated that an artificial intelligence (AI)-based analysis of tumor biopsies can predict responses to immunotherapy in a study of patients with rare cancers, published in the Journal for ImmunoTherapy of Can
Foto: Jonathan Borba / Pexels
Improving growth outcomes for children living with dwarfism
New findings from a trial conducted at Children's Hospital Colorado (Children's Colorado) and University of Colorado (CU) Anschutz School of Medicine demonstrate significantly increased growth rates in children with achondroplasia, the most common form of dwarfism. These results
Brain–computer interface detects hidden awareness in unresponsive patients
A new approach for identifying signs of hidden awareness in people who cannot speak or move after severe brain injury has been demonstrated by researchers at the University of Bath in the U.K.
Preserved testicular tissue produces early germ cells after childhood cancer treatment
Researchers at Karolinska Institutet have demonstrated that it is possible to create early germ cells from preserved testicular tissue of young boys facing cancer therapy. The study, published in the journal Human Reproduction Open, may eventually contribute to new ways of protec
Intermittent fasting maintains long-term weight loss, regardless of meal timing, study sho
A team of scientists from the University of Granada (UGR), the Granada Institute for Biomedical Research (ibs.GRANADA), the Public University of Navarra and the Biomedical Research Networking Center (CIBER) has demonstrated that limiting food intake to an eight-hour window helps
Foto: Pixabay / Pexels
Immature immune cells predict chances of survival following a heart attack
In the event of a severe heart attack, immature immune cells are released into the bloodstream from the bone marrow. A research team led by the University of Münster has demonstrated that the maturity level of neutrophils can be used to determine the short-term risk of death, and
Platinum TALEN enables mass production of engineered cancer-fighting T cells
Hiroshima University researchers have demonstrated a proof of concept for the mass production of genome-edited T cells that can be used to treat malignant tumors, using a genetic engineering technique called Platinum TALEN.